NODELMAN OLEG — SEC insider filings

SEC reporting owner CIK 1454385. 23 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 23 filings on record, filed 2021-02-12 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
ANAPTYSBIO, INC (ANAB)Director, 10% owner513 legs · 1,496,715 sh · $41,405,8781 leg · 668,237 sh · $14,453,966—
Aktis Oncology, Inc. (AKTS)Director12 legs · 2,222,222 sh · $39,999,996—10
Zymeworks Inc. (ZYME)Director, 10% owner920 legs · 2,163,747 sh · $26,071,310—3
Nuvation Bio Inc. (NUVB)Director616 legs · 11,483,868 sh · $21,473,8572 legs · 208,142 sh · $2,072,64213
Panacea Acquisition Corp. II (PANA)Director, 10% owner21 leg · 545,000 sh · $5,450,000—1

Insider filings — NODELMAN OLEG

FiledFormIssuerReported transactionsSource
2026-11-184ANAPTYSBIO, INC (ANAB)
jointly with EcoR1 Capital, LLC
Purchase (P): 84,120 @ $45.66 · Purchase (P): 152,367 @ $45.66 · Purchase (P): 138,093 @ $46.54EDGAR
2026-01-124Aktis Oncology, Inc. (AKTS)
jointly with EcoR1 Capital, LLC
Conversion (C): 2,270,879 · Conversion (C): 202,862 · Conversion (C): 128,506 · Purchase (P): 2,077,779 @ $18 · Purchase (P): 144,443 @ $18 · Conversion (C): 9,913,810 (derivative) · +6 moreEDGAR
2025-06-274Zymeworks Inc. (ZYME)
jointly with EcoR1 Capital, LLC
Option exercise/expiry (X): 5,086,480 @ $0.00 · Tax withholding (F): 41 @ $12.71 · Option exercise/expiry (X): 5,086,521 (derivative) @ $0EDGAR
2025-05-194Zymeworks Inc. (ZYME)
jointly with EcoR1 Capital, LLC
Purchase (P): 49,502 @ $11.43 · Purchase (P): 5,919 @ $11.78EDGAR
2025-04-184Zymeworks Inc. (ZYME)
jointly with EcoR1 Capital, LLC
Purchase (P): 73,953 @ $11.16 · Purchase (P): 54,760 @ $11.52EDGAR
2025-04-074Zymeworks Inc. (ZYME)
jointly with EcoR1 Capital, LLC
Purchase (P): 120,770 @ $11.84 · Purchase (P): 196,438 @ $11.17EDGAR
2025-04-024Zymeworks Inc. (ZYME)
jointly with EcoR1 Capital, LLC
Purchase (P): 4,397 @ $11.75 · Purchase (P): 48,658 @ $11.60 · Purchase (P): 74,360 @ $11.85EDGAR
2025-03-274Zymeworks Inc. (ZYME)
jointly with EcoR1 Capital, LLC
Purchase (P): 53,501 @ $12.91 · Purchase (P): 43,848 @ $12.24EDGAR
2025-03-244Zymeworks Inc. (ZYME)
jointly with EcoR1 Capital, LLC
Purchase (P): 73,476 @ $12.93 · Purchase (P): 31,033 @ $12.78 · Purchase (P): 22,689 @ $13.08EDGAR
2025-03-194Zymeworks Inc. (ZYME)
jointly with EcoR1 Capital, LLC
Purchase (P): 56,277 @ $12.23 · Purchase (P): 113,880 @ $12.65 · Purchase (P): 58,306 @ $12.64EDGAR
2025-03-134Zymeworks Inc. (ZYME)
jointly with EcoR1 Capital, LLC
Purchase (P): 320,690 @ $11.49 · Purchase (P): 292,934 @ $12.25 · Purchase (P): 468,356 @ $12.48EDGAR
2025-01-024ANAPTYSBIO, INC (ANAB)
jointly with EcoR1 Capital, LLC
Purchase (P): 65,184 @ $12.92 · Purchase (P): 13,268 @ $12.93 · Purchase (P): 6,646 @ $12.95EDGAR
2023-09-224/ANuvation Bio Inc. (NUVB)
jointly with EcoR1 Capital, LLC, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P., EcoR1 Venture Opportunity Fund, LP, Biotech Opportunity GP, LLC
Purchase (P): 5,143,000 @ $1.26 · Purchase (P): 117,100 @ $1.36 · Purchase (P): 53,000 @ $1.36EDGAR
2023-09-214Nuvation Bio Inc. (NUVB)
jointly with EcoR1 Capital, LLC, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P., EcoR1 Venture Opportunity Fund, LP, Biotech Opportunity GP, LLC
Purchase (P): 5,143,000 @ $1.26 · Purchase (P): 117,100 @ $1.36 · Purchase (P): 53,000 @ $1.36EDGAR
2023-05-024Panacea Acquisition Corp. II (PANA)
jointly with EcoR1 Panacea Holdings II, LLC, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P., EcoR1 Venture Opportunity Fund, LP, EcoR1 Capital, LLC, Biotech Opportunity GP, LLC
Disposition to issuer (D): 545,000EDGAR
2022-05-094ANAPTYSBIO, INC (ANAB)
jointly with EcoR1 Capital, LLC
Purchase (P): 668,237 @ $21.63 · Sale (S): 668,237 @ $21.63EDGAR
2021-11-304Nuvation Bio Inc. (NUVB)
jointly with EcoR1 Capital, LLC, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P., EcoR1 Venture Opportunity Fund, LP, Biotech Opportunity GP, LLC
Purchase (P): 151,544 @ $10.45 · Sale (S): 151,544 @ $10.45 · Purchase (P): 56,598 @ $8.64 · Sale (S): 56,598 @ $8.64 · Purchase (P): 163,268 @ $7.69 · Purchase (P): 21,758 @ $7.69EDGAR
2021-11-024Nuvation Bio Inc. (NUVB)Grant/award (A): 45,229 (derivative) @ $0EDGAR
2021-05-044ANAPTYSBIO, INC (ANAB)
jointly with EcoR1 Capital, LLC
Purchase (P): 35,700 @ $23.16 · Purchase (P): 20,800 @ $23.31 · Purchase (P): 165,000 @ $23.25EDGAR
2021-04-274ANAPTYSBIO, INC (ANAB)
jointly with EcoR1 Capital, LLC
Purchase (P): 99,600 @ $23.54 · Purchase (P): 13,900 @ $23.80 · Purchase (P): 33,800 @ $23.82EDGAR
2021-04-134Panacea Acquisition Corp. II (PANA)
jointly with EcoR1 Panacea Holdings II, LLC, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P., EcoR1 Venture Opportunity Fund, LP, EcoR1 Capital, LLC, Biotech Opportunity GP, LLC
Purchase (P): 545,000 @ $10EDGAR
2021-04-134Nuvation Bio Inc. (NUVB)
jointly with EcoR1 Capital, LLC, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P., EcoR1 Venture Opportunity Fund, LP, EcoR1 Panacea Holdings, LLC, Biotech Opportunity GP, LLC
Purchase (P): 262,230 @ $10.03 · Purchase (P): 37,770 @ $10.03 · Purchase (P): 116,255 @ $9.49 · Purchase (P): 16,745 @ $9.49 · Purchase (P): 27,534 @ $10.27 · Purchase (P): 3,966 @ $10.27EDGAR
2021-02-124Nuvation Bio Inc. (NUVB)
jointly with EcoR1 Panacea Holdings, LLC, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P., EcoR1 Venture Opportunity Fund, LP, EcoR1 Capital, LLC, Biotech Opportunity GP, LLC
Conversion (C): 2,775,000 @ $0 · Grant/award (A): 2,106,000 · Grant/award (A): 394,000 · Grant/award (A): 2,112,735 @ $10 · Grant/award (A): 387,265 @ $10 · Grant/award (A): 2,365,511 @ $0 · +6 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1454385 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs